Weight Bearing Exercises With NMES on Balance and Functional Abilities In Children With Hemiplegia
Launched by CAIRO UNIVERSITY · Jul 8, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special type of exercise, called weight-bearing exercises, combined with gentle electrical stimulation to the muscles (known as neuromuscular electrical stimulation or NMES), might help improve balance and everyday abilities in children with hemiplegic cerebral palsy. Hemiplegic cerebral palsy is a condition where one side of the body is weaker or less coordinated, affecting movement and balance. The goal is to see if this combined approach can make it easier for children to move and perform daily tasks.
Children who might be eligible for this study are between 6 and 10 years old, diagnosed with hemiplegic cerebral palsy, and have mild muscle tightness in their legs. They should be able to understand and follow simple instructions and have moderate mobility levels. Children with other neurological conditions, recent surgeries, certain treatments, or other health issues like epilepsy or skin sensitivity won’t be able to participate. If chosen, participants will take part in a program where they do specific exercises while receiving gentle electrical stimulation to their muscles, aimed at improving their balance and function. This study is not yet recruiting participants, but it hopes to offer new ways to support children with this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children diagnosed with hemiplegic cerebral palsy.
- • Their age will range from 6-10 years.
- • Both sexes will be included.
- • All participants will be able to follow simple commands.
- • They will be graded as mild spasticity of the lower limbs according to MAS grade 1 to 1+ .
- • They will be at levels I and II based on the GMFCS
- Exclusion Criteria:
- • Children with any neurological conditions other than hemiplegic cerebral palsy will be excluded from the study.
- • Musculoskeletal problems or congenital deformity.
- • Children with fixed contracture.
- • Lower limb surgery in the last one year.
- • Rhizotomy, or injection of botulinum toxin into the lower limb muscles during the previous 6 months.
- • Receive any medications that affect the arousal and alertness status.
- • Children having epilepsy.
- • Visual or auditory defects.
- • Skin sensitivity.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Abdulrahman Mostafa, MSc.
Principal Investigator
Master degree
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported